PEANUT ALLERGY
Clinical trials for PEANUT ALLERGY explained in plain language.
Never miss a new study
Get alerted when new PEANUT ALLERGY trials appear
Sign up with your email to follow new studies for PEANUT ALLERGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New therapy aims to protect kids from dangerous peanut reactions
Disease control OngoingThis study is testing whether an immunotherapy treatment called PVX108 is safe and effective for reducing allergic reactions to peanuts in children and adolescents. Researchers are enrolling 90 participants aged 4-17 with confirmed peanut allergy to see if the treatment helps the…
Matched conditions: PEANUT ALLERGY
Phase: PHASE2 • Sponsor: Aravax Pty Ltd • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New tablet could help protect against accidental peanut exposure
Disease control OngoingThis study is testing a daily dissolving tablet that contains tiny amounts of peanut protein. The goal is to see if it can safely help people with peanut allergy become less sensitive, so they can better tolerate small accidental exposures. The trial involves adults, teenagers, a…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1, PHASE2 • Sponsor: ALK-Abelló A/S • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
First human test for potential peanut allergy therapy begins
Disease control OngoingThis is an early safety study testing a new potential treatment called VLP Peanut for people with peanut allergies. The main goal is to see if the treatment is safe and well-tolerated in a small group of healthy adults and adults with peanut allergy. Researchers will also look fo…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1 • Sponsor: Allergy Therapeutics • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC